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HEXADECANE-INDUCED HYPERKERATINIZATION OF
GUINEA PIG SKIN
III. CUTANEOUS PENETRATION OF TOPICALLY APPLiED HExADEc1C14*
J. D. ROSSMILLER, M.Sc., Pn.D. D W. G. HOEKSTRA, M.Sc., PH.D.
A wide variety of organic compounds includ-
ing certain hydrocarbons, alcohols, organic acids,
amines, and aldehydes produce local epidermal
hyperplasia and hyperkeratosis when applied to
the skin of animals (1—3). The wide diversity in
the compounds capable of initiating this epi-
derrnal response suggests that some property
common to all of the compounds, such as their
lipid-solubiizing property, rather than the pres-
ence of specific functional groups, may be re-
sponsible for their dermatoxic activities. For
such a mechanism of action to be effective it
would appear necessary for substantial amounts
of the dermatoxic agent to penetrate into or
through the epidermis.
Because of the relationship of the dermatoxic
properties of certain mineral oils and their com-
ponents to molecular size, Hoekstra and Phillips
postulated that the dermatoxicity of individual
hydrocarbons was related to their abilities to
penetrate the epidermis (3). In addition it was
noted that some "high-boiling" hydrocarbon
fractions, such as U.S.P. heavy mineral oil, pre-
vented the expression of the dermatoxic proper-
ties of a hydrocarbon, such as n-hexadecane,
when co-applied in equal proportions. It was
proposed that the protective property of the
"higher-boiling", non-toxic hydrocarbon resulted
from its ability to block the epidermal penetra-
tion of the dermatoxic compound.
C-14-labeled hexadecane provided a means of
determining the extent of percutaneous absorp-
tion of topically applied hexadecane and of de-
termining the effect of co-application of certain
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nondermatoxic hydrocarbons on the epidermal
penetration of hexadecane. The results of these
studies are reported in this publication.
METHODS
Male albino guinea pigs were used as test animals
in these experiments. The hair was clipped from the
back of the animals and the C-14-labeled test ma-
terial applied to a 20 cm2 area. After 48 hours the
animals were sacrificed and the residual test ma-
terial removed from the skin surface by wiping with
chloroform-saturated cloths. The epidermis from
the treated area was separated from the dermis by
the stretch method (4). The dermis thus exposed
was thoroughly wiped with a chloroform-saturated
cloth. The dermis and subdermal muscle underlying
the treated area were collected as well as the kid-
neys and liver. Epidermis, dermis, kidney, and liver
were extracted using the chloroform-methanol pro-
cedure of Bligh and Dyer (5). The chloroform was
removed from the extracts under reduced pressure.
The resulting residue was dissolved in toluene and
an aliquot added to 10 ml of scintillation fluid (5.0
gin 2,5-diphenyloxazole (PPO) and 0.3 gui 1,4-bis-
2-5-phenyloxazolyl-benzene (POPOP) per liter of
toluene) and the volume adjusted with toluene to
15 ml. Samples of dried subdermal muscle and blood
were cornbusted in an oxygen combustion appa-
ratus, the CO2 trapped in ethanolamine-methyl-
cellosolve, and an aliquot added to a scintillation
medium containing 5.5 gm PPO per liter of solvent
(toluene : methyl cellosolve 3:2 v/v) (6). The radio-
activity determinations were made using a TriCarb
Liquid Scintillation Spectrometer with a maximum
statistical counting error of less than 5%. Appro-
priate background subtractions were made using
preparations from control animals not treated with
radioactive materials. Quenching corrections were
calculated by the use of internal standards.
The experimental treatments were as follows:
Experiment 1. Effect of application vehicle on the
penetration of hexadecane into and through the epi-
dermis.
Group 1(4 animals) Treated with 0.1 ml hexade-
cane.
Group 2 (4 animals) Treated with 02 ml of an
equal mixture v/v of hexadecane:mineral oil
(tT.S.P. heavy, American Oil Co., Whiting, Indiana).
Group 3 (2 animals) Treated with 02 ml of an
equal mixture v/v of hexadecane : heptane (Skelly-
solve C).
Group 4 (2 animals) Treated with 02 ml of an
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equal mixture v/v of hexadecane : docosane (Puri-
fied, American Oil Co., Whiting, Indiana).
Five /Lc C-14 as n-hexadecane-1-C-14 were pres-
ent in each dose.
Experiment 2. Effect of hexadecane pretreatment
on the epidermal penetration of hexadecane.
Group 1 (2 animals) Treated at 0 and 48 hours
with 0.1 ml unlabeled hexadecane and at 96 hours
with 0.1 ml hexadecane containing 5 c hexadecane-
l-C-14.
Group 2 (2 animals) Treated at 0 and 48 hours
with 0.2 ml of an equal mixture v/v of hexadecane:
heavy mineral oil and at 96 hours with 02 ml of this
mixture containing 5 sc hexadecane-1-C-14.
n-Hexadecane-1-C-14 was obtained from the
ChemTrac Corporation, Cambridge, Massachusetts.
No purification procedures were carried out on this
material. Data from experiment 1 were analyzed
by the use of Duncan's Multiple Range Test for
samples with unequal replication (7). Since only
two animals were included in the treatment groups
of experiment 2, statistical analyses of the data were
not meaningful.
TABLE I
Experiment 1. C-14 present in the epidermis of the
treated area (expressed as counts per minute per
gram of fresh tissue and as a percentage of the
applied dose) 48 hours following the topical ap-
plication of 5 /sc hexadecane-1 -C-14
lO % of dose for entiretreated area
Individual
values Mean
Individual
values Mean
Group 1*, Hex-
adecane (H)
Group 2*, (H):
Mineral oil
Group 3, (H):
Heptane
Group 4, (H):
Docosane
6.45, 3.15
1.64, 2.58
1.99, 1.90
1.27, —
4.80
2.11
1.95
1.27
19.2, 11.1
2.6, 6.2
5.6, 6.1
3.0, —
15.2t
4.4t
5.Sf
3.Of
Duncan's multiple range test—Groups not under-
lined by the same line are significantly different
(P < .05)
* Only 2 of the four epidermal samples in each
of these two treatment groups were analyzed for
C-14.
t The mean of group 1 was significantly different
(P < .05) from the means of groups 2, 3 and 4; no
significant differences (P > .05) were found for
the other comparisons.
RESULTS
Forty-eight hours after application up to 20%
of the topically applied dose of hexadecane-C-14
was found in the epidermal tissue of the treated
area. The procedure used to remove the residual
test material from the skin surface was found,
by measuring C-14 in repeated wipings, to be
effective; therefore, the C-14 present in the epi-
dermal samples represented hexadecane that had
penetrated into the epidermis. The dermis un-
derlying the treated area contained a readily
measurable 0.1% of the applied dose of C-14 and
the liver and kidneys a total of about 0.1%. The
blood did not contain measurable amounts of
C-14.
Experiment 1. Forty-eight hours following
topical application more (P < .05) C-14 from
hexadecane-1-C-14 was found in the epidermis
(Table I) of animals treated with hexadecane
alone than in those treated with an equal
amount of hexadecane admixed with heptane,
docosane, or mineral oil. It should be noted that
some epidermal hyperplasia occurred during the
48 hour treatment period particularly in lots 1
and 3, thus influencing the C-14 content ex-
pressed as cpm per gram of fresh epidermis.
However, when the epidermal C-14 content was
expressed as a % of applied dose for the entire
treated skin area, similar differences between
treatment groups were obtained. The highest
concentration of C-14 in the dermis (Table II)
Experiment . Pre-treatment of the skin with
unlabeled hexadecane (Table IV) did not de-
crease, but appeared to increase, the amount of
C-14 taken up by the epidermis from a subse-
was also found in the group treated with hexa-
decane only; admixtures of mineral oil with
hexadecane caused the dermis to contain only
40% of that amount (P < .05). The accumula-
tion of C-14 in the dermis was also lowered
(P < .05) by adding docosane to hexadecane but
was not significantly decreased (P > .05) by
adding heptane. Similar treatment effects to
those found for dermis were found for C-14 in
the subdermal muscle (Table III) except that
radioactivity per unit weight of tissue was less.
The atypically low level of C-14 found in the
Group 4 Group 3 Group 2 Group 1 subdermal muscle sample of the first-listed aid-
1.27 1.95 2.11 4.80 mal of group 1 is unexplained. The C-14 con-
tents of kidney and liver were low and no
significant difference was found between treat-
ments.
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quent application of labeled hexadecane. The
mean C-14 content of the epidermis was about
50% higher in hexadecane pretreated animals
than in those receiving the single application,
however, the small number of animals precludes
drawing a definite conclusion. Application of
hexadecane in mineral oil again resulted in re-
duced penetration of the labeled alkane; in fact,
the protective effect of mineral oil was height-
ened by pre-treatment since the amount of
C-14 in the epidermis and dermis was only one
half that from the corresponding single ap-
plication (Table IV).
DISCUSSION
About 20% of the topically applied C-14 (as
hexadecane-1-C-14) was taken up by the epi-
dermis at 48 hours, however, the amounts re-
covered in subepidermal tissues were small.
Thus, the epidermis provided a considerable
barrier to the penetration of this alkane. The
relationship of these findings to the hydrocarbon
dermatoxicity problem is difficult to assess be-
cause of two unknown factors. The first of these
unknowns related to the precise location of the
hexadecane within the epidermis (cornified vs.
vital layers) and the second to the site or
mechanism of action of the hydrocarbon in in-
ducing tissue proliferation.
The most pertinent findings from these ex-
periments which bears on these questions were
that simultaneous application of mineral oil,
docosane, or heptane with hexadecane all re-
duced the uptake of hexadecane by the epi-
dermis, however, only mineral oil and docosane
reduced the amount of hexadecane which pene-
trated into the dermis and subdermal muscle.
Co-application of docosane or mineral oil with
hexadecane also prevents hexadecane-induced
hyperplasia and hyperkeratosis whereas heptane
is not effective in this regard (3). This correla-
tion provides some evidence that penetration
of hexadecane into the dermis is essential for the
initiation of its dermatoxic potential. The re-
duced uptake of hexadecane by the epidermis
when applied in a vehicle is possibly a dilution
effect. If the epidermis has a finite capacity to
absorb hydrocarbons, then equal mixtures of
hexadecane : vehicle would be expected to reduce
the amount of hexadecane taken up by the epi-
dermis by about 50% assuming that no specific
absorption takes place. This was essentially the
observed result.
TABLE II
Experiment 1. C-14 present in the dermis under-
lying the treated area (expressed as counts per
minute per gram of fresh tissue) 48 hours following
the topical application of 5 zc hexadecane-1 -C-14
cpm/gn2
Individual values Mean
Group 1, Hexade-
cane (H)
Group 2, H:Min-
eral oil
Group 3, H:Hep-
tane
Group 4, H:Doco-
sane
2060; 3760; 900; 1170
1140; 700; 540; 760
1410; 1810
1140; 940
1970
780
1610
1040
Duncan's multiple range test—Groups not under-
lined by the same line are significantly different
(P < .05)
Group 2 Group 4 Group 3 Group 1
780 1040 1610 1970
TABLE III
Experiment 1. C-14 present in subderinal muscle
(expressed as counts per minute per gram of
fresh tissue) 48 hours following the topical appli-
cation of S sc hexadecane-1 -C-14
cpm/gm
Individual values Mean
Group 1, Hexadecane
(H)
Group 2, H:Mineral
oil
Group 3, H:Heptane
Group 4, H:Doco-
sane
47; 398; 196; 258
64; 72; 202; 34
132; 167
64; 113
225
93
150
89
Duncan's multiple range test-Groups not under-
lined by the same line are significantly different
(P < .05)
Group 4 Group 2 Group 3 Group 1
89 93 150 225
In 1964 Huang, Wheeldon, and Thompson re-
ported on the formation of a lipid membrane
from a system composed of highly purified phos-
phatidylcholine and n-tetradecane dissolved in
a chloroform-methanol solvent (8). The mem-
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TABLE IV
Experiment L Effect of hexadecane pretreatment and of admix ture of heavy mineral oil on the penetration
of labeled hexadecane. C-14 present in tissues (expressed as counts per minute per gram of fresh tissue)
48 hours following the topical application of hexadecane-1-C-14
48 Hour pre-treatment No pre-treatment
Hexadecane Hexadecane:mineral oil Hexadecane Eexadecane:mineral oil
Epidermis
Dermis
Subdermal muscle
cpm/gm
807,000
431,000
2,750
700
380
240
mean
cpm/gm
619,000
1,730
310
.
cpm/gm
65,000
138,000
420
340
30
140
mean
cpm/gm
101,700
380
90
mean
cpm/mg
480,000
1,970
220
mean*
cpm/gm
210,000
780
90
* Mean data taken from Table I.
brane had similar dimensions to the proposed
membrane models (9) and permeability and
electrical properties compatible with a mem-
brane composed of lipid, hydrocarbon, and
water. Treherne measured the penetration of
several radioactive materials through excised
rabbit skin and calculated permeability con-
stants for these materials (10). The data showed
agreement with theoretical values for penetra-
tion through a lipoid-water-lipoid sandwich.
These observations suggest that hydrocarbons
and certain other organic solvents of a particu-
lar size or configuration may be able to fit into
the cell membrane matrix and thereby affect the
integrity and functional properties of the mem-
brane. This could be a potential mechanism of
action for these materials at the cellular level
which could be effective at either the epidermal
or dermal level.
The experiments measuring the effects of pre-
treatment upon penetration provides some ex-
planation for the observation that multiple ap-
plication increases the severity of the response to
hexadecane (11). The observed increase in the
level of C-14 in the epidermis of pretreated
animals may be a reflection of a reduction in
the ability of the epidermis to prevent penetra-
tion perhaps as a result of tissue disruption from
the earlier applications.
The ability of high-boiling hydrocarbons to
prevent the expression of the dermatoxic po-
tential of lower-boiling hydrocarbons apparently
can be explained on the basis of their ability to
interfere with the penetration of the dermatoxic
material. The data herein presented on the effect
of vehicle on the accumulation of hexadecane in
the dermis and subdermal muscle and the report
of Hoekstra and Phfflips (3) on the reduction of
hexadecane dermatoxicity by mineral oil co-
application minimize the role of simple dilution
in this process.
SUMMARY
The C-14 content of epidermis, dermis, sub-
dermal muscle and certain other tissues was de-
termined 48 hours following topical application
of hexadecane-1-C-14 to the skin of guinea pigs.
The effect of simultaneous application of U.S.P.
heavy mineral oil, n-docosane, and heptane as
well as hexadecane pre-treatment on the extent
of penetration of hexadecane-1-C-14 was also
measured.
Large amounts of C-14 were found in the epi-
dermis whereas relatively little accumulated in
the dermis and underlying tissues. Each of the
carrier vehicles reduced the amount of C-14 in
the epidermis; whereas, docosane and mineral
oil, but not heptane, reduced the amount of C-14
in the dermis and subdermal muscle. This cor-
related with the ability of heavy mineral oil and
docosane, but not heptane, to decrease the
dermatoxic effects of hexadecane. Pre-treatment
of the skin with hexadecane 48 hours prior to
application of hexadecane-1-C-14, if anything,
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increased the amount of the C-14 in the epi-
dermis; however, pre-treatment with mineral
oil: hexadecane reduced the amount of epidermal
and dermal C-14 from a subsequent application
of mineral oil: hexadecane-1-C-14.
The results support the proposal that heavy
mineral oil and alkanes with a chain length of
over 20 carbon atoms reduce the dermatoxic
effect of hexadecane by interfering with its pene-
tration to the site of action. This site would ap-
pear to be either the deeper layers of epidermis
or possibly the dermis. The increased uptake of
hexadecane-C-14 by the epidermis following pre-
treatment with hexadecane provides a possible
explanation for the more severe response seen
with multiple hexadecane applications as op-
posed to a single application of the same amount
of material.
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